FORM institutional options flow analysis — multi-leg block trades, dominant direction, and gamma analysis from the public options tape for April 24, 2026. Articles older than 60 days are public; a free account reads back to 30 days, Pro to 5, and AIme Premium reads today's unusual options trades with no delay.

AInvestOption Pilot Program
Unusual FlowDaily DigestFORM Ticker Page

FORM Unusual Options Activity — 2026-04-24

Institutional flow on 2026-04-24

Multi-leg block trades, dominant direction, and gamma analysis

$1.3M1 trade
Long Call

Trade Details

BUY$170 CALL2026-05-15$1.3MLong Call

Full Analysis

🚀 FORM $1.3M Earnings Bet — Someone Is Loaded Up on HBM4 Going Into April 29!

📅 April 24, 2026 | 🔥 Unusual Activity Detected

🎯 The Quick Take

Someone just dropped $1.3 MILLION on FORM calls at 12:22 today — 2,400 contracts at the $170 strike expiring May 15, with the stock sitting at $157.46. That's a bold bet that FORM rips more than 8% above today's price in 21 days, with Q1 2026 earnings dropping in just 5 days on April 29. Translation: this trader is betting the HBM4 probe-card story goes nuclear at the print, and they need the stock to clear a new all-time high to cash in.

📊 Company Overview

FormFactor (FORM) is the global #1 in advanced semiconductor probe cards — the precision test sockets that plug into Advantest and Teradyne testers to verify every chip works before it ships.

  • Market Cap: ~$12B (Semiconductor Test & Metrology)
  • Industry: Semiconductor Equipment — Probe Cards + Cryogenic Test Systems
  • Primary Business: DRAM/HBM probe cards (largest segment), Foundry & Logic probe cards for leading-edge AI accelerator SoCs, and HPD-branded cryogenic probe stations for quantum computing R&D
  • Why it matters now: Every High Bandwidth Memory chip (HBM4) heading into NVIDIA's next Rubin GPU platform needs FormFactor's probe cards to get tested — more HBM layers = more test intensity = more revenue for FORM
  • 52-Week Range: $26.08 – $152.00; current ~$157.46 (yes, this thing has been on a rocket ship 🚀)

💰 The Option Flow Breakdown

📊 The Tape — April 24, 2026

TimeSymbolSideBuy/SellTypeExpirationPremiumStrikeVolumeOISizeSpotOption PriceOrder TypeStrategy
12:22:01FORMASKBUYCALL $1702026-05-15$1.3M$1702,400871,200$157.46$11.00BTOLong Call

🤓 What This Actually Means

This is a pure directional earnings bet — aggressive, tight, and expiring fast. Here's the breakdown:

  • 💸 $1.3M premium paid: $11.00 per contract × 1,200 contracts (split into 2 fills of 1,200 over the tape — 2,400 total volume vs. 87 OI means this is almost entirely fresh money)
  • 🎯 Strike is 8% OTM: With FORM at $157.46, the $170 call needs a significant move — this isn't a conservative hedge, it's a conviction play
  • ⏰ 21 DTE with earnings in 5 days: The 2026-05-15 expiration captures the April 29 Q1 print AND leaves 16 days of post-earnings follow-through time. The trader is betting the catalyst AND the momentum
  • 📊 Volume vs. OI: 2,400 contracts printed against just 87 open interest — that's a Vol/OI ratio of 27.6x. This is fresh positioning, not someone closing or rolling an existing trade
  • 🐋 Not your neighbor Bob: This is someone writing a $1.3M check to bet FORM clears $181 (breakeven including premium) by May 15 — well above the current all-time high of $152

Real talk: The size of this trade relative to existing open interest is the signal. With 87 OI and 2,400 volume hitting the ASK, a single player loaded up on a fresh bullish position five days before a potentially catalytic earnings print. They either have very high conviction in a beat-and-raise, or they know something the market doesn't about the HBM4 ramp trajectory.

📈 Technical Setup / Chart Check-Up

YTD Performance Chart

FORM YTD Chart

FORM has been one of the most explosive semi-equipment names of 2026. The stock launched from sub-$100 in early February after a strong Q4 2025 beat and guidance raise to $225M for Q1 2026 — a +11% revenue beat vs. prior Street consensus. Then Cantor Fitzgerald raised their target to $125 on April 8 and FORM exploded again, gapping +8% on April 17 to $137 before continuing to the $150+ zone. The stock has now broken above its prior 52-week high of $152.

Key observations:

  • 🚀 ~55-60% rally in 3 months: From ~$97 to $157+ driven entirely by HBM4 and AI probe card demand
  • 📊 Breakout mode: Stock printed a new all-time high just days ago — technically in uncharted territory with no overhead resistance from prior highs
  • ⚠️ Earnings overhang: The whole move has been driven by expectations for April 29 — the print will either confirm the thesis or create a "sell the news" trap
  • 🔥 Volume surges confirm institutional accumulation: Multiple high-volume days above the 200-day average in March–April show real money rotating in

Gamma-Based Support & Resistance Analysis

FORM Gamma S/R

Current Price at Close: $158.18

The gamma exposure map shows a clear picture of where market makers are positioned and how they'll influence near-term price action:

🔵 Support Levels (Put Gamma / Call Gamma Floors Below Price):

  • $155 — Nearest support, strongest nearby floor (total GEX: 0.061). Only 2% below current price — this is the line dealers defend first on any dip
  • $150 — Secondary support (total GEX: 0.035), roughly 5% below current. A key round number with meaningful options open interest acting as a gravitational floor
  • $145 — Extended floor (total GEX: 0.023), 8% below — the "panic level" if earnings disappoint
  • $140 — Deep structural support (total GEX: 0.026), 11% below. A gap to here would likely see aggressive buy-the-dip institutional activity
  • $135 — Interesting level: call GEX and put GEX are almost equal (0.0107 vs. 0.0101), meaning this acts as a true pinning zone — 14.6% below current
  • $130 — The biggest total GEX level (0.071) in the entire map, sitting 18% below. This is the ultimate floor where dealer hedging would be most aggressive — a post-earnings meltdown target if things go really wrong

🟠 Resistance Levels (Call Gamma Ceilings Above Price):

  • $160 — Immediate ceiling (total GEX: 0.025), just 1.1% above current price. Market makers will be selling into strength here — this is the near-term wall to watch
  • $170 — KEY LEVEL (total GEX: 0.017), 7.5% above current. This is exactly where the big trade was struck. Heavy call gamma here means dealers will systematically sell as price approaches — the trader needs to overcome this mechanical headwind
  • $175 — Extended resistance (total GEX: 0.007), 10.6% above
  • $180 — Outer ceiling (total GEX: 0.006), 13.8% above — the upper range of the implied move

Net GEX Bias: 🟢 Bullish (total call GEX 0.409 vs. total put GEX 0.139) — overall positioning is net long gamma. Dealers are positioned to buy dips and sell rips, creating a natural stabilizing effect — good for the stock near support but a headwind at resistance.

What this means for the $170 call trade: The trader is betting FORM busts through the $160 dealer resistance AND the $170 call gamma wall. That requires a sustained institutional bid — exactly what an earnings beat-and-raise catalyst could provide if it's big enough to overwhelm mechanical dealer selling.

Implied Move Analysis

FORM Implied Move

Options market pricing for the May 15 expiration:

  • 📅 Monthly OPEX (May 15 — 21 days): ±$25.63 (±16.5%) → Range: $129.45 – $180.71
  • Current price used for implied move: $155.08

Translation for regular folks: the options market is pricing in a $25+ swing in either direction over the next 3 weeks. The upper range lands almost exactly at $180.71 — which means the $170 call is WITHIN the options market's expected upside move. The trader isn't betting on a black swan, they're betting on the upper half of the implied move scenario playing out.

Key insight: The $170 strike sits at roughly 94% of the implied upper range ($180.71). The market thinks FORM has a real shot at hitting $170+ — the question is whether the April 29 catalyst provides enough fuel to get there in 21 days. The breakeven for the long call trade ($170 strike + $11 premium = $181 breakeven) is actually just above the options market's implied ceiling. That's the risk in a nutshell.

🎪 Catalysts

🔥 Upcoming Catalysts (Next 30 Days)

Q1 2026 Earnings — April 29, 2026 (5 DAYS AWAY!) 📊

This is the entire thesis. FormFactor reports Q1 2026 earnings on April 29 at 1:25 PM PT / 4:25 PM ET. Key numbers to watch:

  • 📊 Company Guidance: $225M revenue (±$5M) — already issued in February, well above old Street consensus of $202.8M. The bar has been re-set; the market needs FORM to beat its own guide AND raise Q2
  • 💰 Non-GAAP EPS Guide: ~$0.41–0.49 vs. old Street consensus of $0.27 — a potential 50%+ beat on EPS if delivered, per Ticker Report
  • 🧠 The real bar: Did the all-time DRAM record the company called out in February actually materialize? And more importantly, what does Q2 guidance look like?
  • 📈 Gross margin target: ~45% non-GAAP (+100 bps sequential) — margin expansion is crucial for the valuation story at 15x trailing sales

Five key metrics every trader must watch on April 29:

  1. DRAM segment revenue — all-time record baked in; a miss here is catastrophic
  2. Foundry & Logic revenue — AI accelerator traction from NVIDIA and AMD sockets
  3. Q2 2026 revenue guidance — must be visibly above $225M to sustain the stock's run
  4. Farmers Branch capex update — is the $140M Texas investment on schedule?
  5. China as % of revenue — already collapsed from 14% to 7%; any further color matters

HBM4 Ramp from SK Hynix, Samsung, and Micron 🧬

All three major DRAM makers are actively sampling HBM4 with NVIDIA as of Q1 2026. TrendForce confirmed SK Hynix leads with 16-layer 48GB HBM4, with mass manufacturing targeted to begin H2 2026. EE Times noted the HBM4 technology maturity curve is steep, requiring significant requalification of probe cards across multiple customer variants — every one of those requalification cycles is billable revenue for FormFactor.

Each incremental HBM layer added (from HBM3E to HBM4's 12–16 layers) creates exponentially more known-good-die (KGD) test intensity — this is FormFactor's sweet spot and the core bull thesis.

NVIDIA Rubin Platform 🤖

FormFactor's share gains in foundry/logic probe cards for NVIDIA and AMD AI accelerators were highlighted by sell-side analysts at GTC 2026. The Rubin platform launch in late 2026 / early 2027 drives the next socket-level probe card attach cycle at leading-edge nodes. B. Riley's April 17 report explicitly called out these share gains even while downgrading on valuation — a meaningful signal about underlying demand.

Farmers Branch Texas Expansion 🏭

FormFactor committed >$140M of 2026 capital investment into the new Farmers Branch, TX facility — 50,000 sq ft of clean room space targeting qualification by mid-to-late 2026. This site comes online just as HBM4 mass production begins, a deliberate strategic timing play. Any update on April 29 about qualification milestones would be a meaningful positive catalyst.

Bluefors Modular Cryogenic Platform — Quantum Computing Wildcard 🔬

Bluefors announced a breakthrough Modular Cryogenic Platform on March 3, 2026 enabling "hundreds of thousands of qubits" with first multi-module deliveries expected in late 2026. FormFactor's HPD IQ3000 and IQ1000 SQUID Microscope cryogenic probe stations are the de-facto standard for superconducting quantum device R&D — this expands the addressable quantum test market just as FormFactor has unique product positioning. Small revenue contribution today, but a differentiated long-term optionality play.

📅 Recent Catalysts (Already Happened)

🎲 Price Targets & Probabilities

Using gamma levels, implied move data (±$25.63, ±16.5%), and the upcoming April 29 earnings catalyst, here are the three scenarios through the May 15 expiration:

📈 Bull Case — 30% Probability

Target: $170–$181

How we get there:

  • 💪 FORM beats its own Q1 guide: revenue above $230M (not just the $225M they telegraphed), with gross margins at the high end of the 45% ±150 bps range
  • 🚀 DRAM all-time record confirmed with HBM4 pull-forward commentary from SK Hynix and Samsung
  • 📊 Q2 2026 guidance raised meaningfully above $225M — this is the key unlock. The stock is pricing in a visible growth ramp, not a one-quarter wonder
  • 🤖 Foundry/logic AI accelerator socket wins mentioned explicitly — NVIDIA Rubin and AMD MI-series traction confirmed
  • 🏭 Farmers Branch qualification on track — no capex surprises
  • 📈 Stock breaks through the $160 gamma resistance wall on earnings gap, then the $170 call gamma wall becomes a magnet as dealers cover short gamma exposure above
  • 🎯 The $170 option buyer makes money at anything above $181 (breakeven = strike + premium). A move to $175–$180 generates meaningful but not maximum return; $181+ is where this trade really pays

Why only 30%: The stock has already moved 55-60% in 3 months pricing in much of this optimism. The "beat and raise" must be material to justify another leg up into all-time highs. And the breakeven at $181 sits just above the options market's implied upper range of $180.71 — the math is tight.

🎯 Base Case — 45% Probability

Target: $148–$165 (Post-Earnings Consolidation)

Most likely outcome:

  • ✅ FORM delivers solidly in-line with its own guidance: $220–$228M revenue, 44–46% non-GAAP gross margin — good but not spectacular
  • 📊 Q1 DRAM record confirmed but Q2 guidance only modestly above $225M (not the step-change needed)
  • 🔄 Classic "buy the rumor, sell the news" after a 55-60% pre-earnings run — stock pulls back 5-10% to the $145–$155 gamma support zone
  • 💨 Implied volatility collapses post-earnings from elevated pre-earnings levels — the $170 call bleeds rapidly even if stock holds flat or rises modestly
  • 📉 The $170 call buyer loses most or all of their $1.3M as time decay + IV crush + stock below breakeven combine

This is the danger zone for the long call trade: Even if FORM reports "good" numbers, the stock sitting at $155-165 post-earnings means the $170 call expires worthless with the premium evaporating. The trader needs not just a good print but an outstanding one.

📉 Bear Case — 25% Probability

Target: $130–$145 (Sell The News / Miss)

What could go wrong:

💡 Trading Ideas

🛡️ Conservative: Wait for Earnings Clarity

The "Sleep Well" Play

Don't touch options into binary earnings events on stocks that have already run 55-60%. Let the print happen, let IV crush, then reassess.

Why this works:

  • ⏰ Implied volatility is elevated pre-earnings — options are expensive. Post-earnings, IV collapses and you can buy the same strikes for significantly less
  • 📊 The gamma analysis shows $155 is immediate support and $150-$130 are strong floors. If FORM dips post-earnings on an "in-line" print, those levels offer much better risk/reward for entry
  • 🎯 If the earnings are genuinely beat-and-raise, the stock will still be buyable after the initial spike — you don't need to be in before the casino opens

Action plan:

  • 👀 Watch the April 29 earnings call (1:25 PM PT) closely — key things to listen for: Q2 guidance vs. $225M, HBM4 customer specifics, Farmers Branch update
  • 🎯 If stock dips to $145–$150 post-earnings on an in-line print, consider buying July calls (longer duration) after IV crush — much better risk/reward than the current 21-day $170 calls
  • ✅ Only enter new options positions once the binary event risk has resolved

Risk level: Minimal | Skill level: Beginner-friendly

⚖️ Balanced: Post-Earnings Bull Call Spread

The "Measured Bet" Strategy

After the April 29 print, if FORM trades $150-160, buy a bull call spread to define your risk while maintaining upside exposure.

Structure: Buy $160 calls / Sell $175 calls (May 15 expiration — same as the big trade)

Why this works post-earnings:

  • 💨 IV crush dramatically reduces premium cost — what costs $8-10 today might cost $4-5 after earnings settle
  • 📊 $15-wide spread caps max risk at net debit while allowing participation in a post-earnings rally
  • 🎯 Profit zone: $164-175 on FORM, which aligns with the $160-170 gamma resistance zone. If earnings are good, the stock drifts into that range over 2-3 weeks
  • 🔒 Defined risk — you know exactly what you can lose before you enter

Estimated P&L (post-earnings, assuming IV normalizes):

  • 💰 Net debit: ~$4-5 post-IV crush (vs. $11+ today)
  • 📈 Max profit: $10-11 per spread if FORM above $175 at May 15 expiration
  • 📉 Max loss: $4-5 (only the debit paid) — much more manageable than raw long calls
  • 🎯 Breakeven: ~$164-165 post-IV crush

Entry timing: Wait 1-2 days post-earnings for volatility to settle before entering

Risk level: Moderate (defined risk, directional) | Skill level: Intermediate

🚀 Aggressive: Follow The Whale (ADVANCED ONLY!)

The "Copycat Earnings YOLO" — $170 Call BTO

Same trade as the institutional player: buy the May 15 $170 calls outright, betting FORM rips above $181 by May 15.

Why someone would do this:

  • 💥 If FORM beats-and-raises materially, these calls could 3-5x overnight on an earnings gap
  • 🤖 The HBM4 structural tailwind is real — SK Hynix, Samsung, and Micron are all in active HBM4 ramp mode, and FORM's DRAM segment grew +15.8% YoY last quarter
  • 📊 The options market gives the trade some probability of success — the $170 strike is within the implied move range ($180.71 upper)
  • ⏰ 21 DTE means 16 days post-earnings for momentum to carry the stock higher

Why this is genuinely dangerous (SERIOUS RISKS):

  • 💸 BREAKEVEN is $181: The stock needs to gain another 15% from current levels just to break even. That requires both the earnings gap AND sustained follow-through
  • 😱 IV crush kills you even on a modest beat: If FORM pops to $165 on earnings (a good move!), the $170 call is still OTM and IV crush eats most of the remaining time value. You can be right on direction and still lose 70-80% of your premium
  • ⏰ Time decay accelerates: With 21 DTE, theta burns approximately $0.35-0.50 per contract per day — before you even account for volatility moves
  • 🎰 The stock has ALREADY run 55-60%: You'd be paying $11 on a stock that's priced for perfection. The expected value math here is tough
  • 📉 Total loss scenario: Stock flat or down on earnings. All $1.3M goes to zero. For retail, size this to what you can genuinely afford to lose entirely

Estimated scenarios at expiration:

  • 🚀 FORM at $185 (home run): Call worth ~$15 → profit of $4/contract, ~36% ROI on $11 paid
  • 📈 FORM at $175 (solid): Call worth ~$5 → loss of $6/contract, -55% loss
  • 😰 FORM at $165 (modest beat, sell the news): Call worth ~$0 → -100% loss
  • 💀 FORM at $155 or below: Call worthless → -100% loss

CRITICAL WARNING: Only attempt this if you:

  • ✅ Can genuinely afford to lose 100% of the premium deployed
  • ✅ Have traded through earnings events before and understand IV crush mechanics
  • ✅ Size it to 1-3% of portfolio MAX — not the $1.3M the whale bet (they have portfolio hedges we don't see)
  • ✅ Have a plan to cut losses quickly if the stock doesn't gap meaningfully higher at the open on April 30

Risk level: EXTREME | Skill level: Advanced only | Probability of profit: ~25-30%

⚠️ Risk Factors

Don't ignore these before making any move:

  • ⏰ Binary earnings event in 5 days: The April 29 print creates the most dangerous options environment — elevated IV means you're overpaying for premium before the event, and IV crush means you may lose money even on a positive outcome. The implied move of ±$25.63 (±16.5%) is enormous for a semiconductor equipment stock — don't underestimate the range of outcomes

  • 💸 "Priced for perfection" at 15x trailing sales: FinancialContent's HBM4 era analysis explicitly flags this — with a ~$12B market cap on ~$785M 2025 revenue, the stock has zero margin for error. The print must beat guidance AND raise Q2 to justify the current spot. A meet-guidance quarter could still trigger a 10-15% selloff

  • 👔 Insider selling at $90-96 while stock is at $157: CEO Mike Slessor sold 10,227 shares at ~$95.15 in March 2026 and CFO Aric Mckinnis sold at $90.42. The aggregate insider selling of ~102,562 shares worth $7.87M at prices 40-50% below today's $157 is worth noting. Yes, these can be programmatic 10b5-1 plans — but insiders exiting at $90-96 while buy-siders pile in at $157 is a sentiment check

  • 🏭 Farmers Branch execution risk: More than $140M of 2026 capex is riding on a brand-new facility that has never been qualified. Any delays to the clean room build-out or probe card qualification process could compress margins in H2 2026 exactly when HBM4 revenue is supposed to ramp. This is the biggest operational risk the market may be underweighting

  • 🇨🇳 China already a small slice — but not zero: China has already collapsed from 14% to 7% of revenue per FormFactor's 10-K. The BIS advanced AI chip export rule effective January 15, 2026 could further restrict China-destined DRAM/foundry customer products. Limited upside from a policy reversal, but meaningful downside if restrictions tighten

  • 📊 HBM4 technology transition risk: EE Times flagged a steep maturity curve for HBM4 — shifting to 12-16 layer stacks with hybrid bonding requires FormFactor to requalify probe cards across multiple customer variants simultaneously. This increases engineering bandwidth requirements and could delay revenue capture from any single customer

  • 🐻 Contrarian valuation target of $98: WallStreetZen's target of $98.29 represents ~35% downside from current levels. This isn't a mainstream call, but it reflects real concern about cyclical semiconductor equipment stocks trading at software-like multiples — if the WFE upcycle slips even one quarter, multiple compression could be brutal

  • 🌍 Tariff uncertainty: April 2026 tariff-related announcements have introduced semiconductor-equipment tariff uncertainty that could affect FormFactor's global manufacturing cost structure, particularly for components sourced internationally for the new Texas facility

🎯 The Bottom Line

Real talk: Someone just committed $1.3M to the thesis that FORM clears $181 in 21 days — betting the HBM4 story doesn't just continue but accelerates at the April 29 print. This is a high-conviction, high-risk, tight-window trade that needs a lot of things to go right simultaneously: the Q1 beat must clear $225M guidance, Q2 must guide materially higher, and HBM4 commentary must confirm the structural multi-year demand thesis.

What this trade tells us:

  • 🎯 The 27.6x Vol/OI ratio signals this is fresh positioning — not a hedge, not a roll, but someone buying new exposure five days before the most important earnings report of FORM's recent history
  • 💰 Paying $11 for $170 calls on a $157 stock with 21 DTE is an aggressive choice — it implies the buyer genuinely thinks there's a meaningful probability of a large post-earnings gap
  • ⚖️ The $170 strike corresponds exactly to a gamma resistance level in the GEX analysis — the buyer is positioning where dealers are short, meaning an earnings catalyst could create a short squeeze in the options market itself

If you already own FORM stock:

  • ✅ Consider trimming 20-30% into earnings — locking in gains from the 55-60% run and reducing binary event exposure is prudent portfolio management
  • 📊 Set your mental stop at $150 (key gamma support) — if FORM cracks there post-earnings, the "priced for perfection" thesis is broken
  • 🎯 If you hold and FORM delivers a true beat-and-raise, consider selling covered calls at $175-180 to capture elevated post-earnings IV and generate income

If you're watching from the sidelines:

  • ⏰ April 29 at 1:25 PM PT is the moment of truth — do NOT enter new positions before earnings if you're not comfortable with 100% premium loss scenarios
  • 🎯 Post-earnings pullback to $145–$150 would be a more compelling entry — those gamma support levels are real, and you'd be buying with IV already collapsed and the binary risk resolved
  • 🚀 The HBM4 structural story is compelling and multi-year: TrendForce sees mass HBM4 production ramping H2 2026 with NVIDIA Rubin as the demand anchor. FORM doesn't need to "win" April 29 perfectly for the stock to work over 12-18 months

If you're bearish:

  • 📊 The gamma map shows $148–$155 as the first real support zone. A post-earnings disappointment could flush FORM to that level in a single session
  • ⚠️ Shorting FORM into earnings is fighting a stock at all-time highs with institutional accumulation behind it — defined-risk put spreads post-earnings are safer than outright shorts or naked puts

Mark your calendar — Key dates:

  • 📅 April 29, 2026 at 1:25 PM PT — Q1 2026 earnings release (5 DAYS!)
  • 📅 April 29 at 4:25 PM ET — Conference call with Q2 2026 guidance
  • 📅 May 15, 2026 — Expiration date for the $170 call trade and Monthly OPEX
  • 📅 July 7-10, 2026 — Semicon West in San Francisco (industry catalyst)
  • 📅 H2 2026 — Farmers Branch Texas qualification + HBM4 mass production ramp begins
  • 📅 Late 2026 / early 2027 — NVIDIA Rubin platform launch (next major cycle catalyst)

Final verdict: The $1.3M long call is a high-stakes earnings bet from someone with strong conviction in the HBM4 story. The setup — 8% OTM, 21 DTE, priced at 27.6x existing open interest — tells you this is speculative, not conservative. The bull thesis is real and well-supported by HBM4 momentum from SK Hynix, Samsung, and Micron, NVIDIA Rubin cycle tailwinds, and Bluefors quantum platform expansion. But the execution bar is steep, the breakeven is above the options market's own implied ceiling, and insider selling 40-50% below today's price is a sobering data point.

Be honest with yourself about position sizing. The whale can absorb a $1.3M total loss. Can you?

Disclaimer: Options trading involves substantial risk of loss and is not suitable for all investors. This analysis is for educational and informational purposes only and does not constitute financial advice. Past performance does not guarantee future results. The options activity described may reflect hedging, speculation, or institutional strategies not applicable to retail traders. Earnings events create binary risk with potential for significant losses on both sides. Always do your own due diligence and consult a licensed financial advisor before trading. Never risk more than you can afford to lose entirely.

About FormFactor (FORM): FormFactor designs and manufactures advanced semiconductor probe cards and cryogenic test systems, serving global customers in DRAM/HBM memory, foundry/logic AI accelerator SoCs, and quantum computing R&D. Market cap approximately $12B in the Semiconductor Equipment industry (ELECTRONIC COMPUTERS / Semiconductor Test & Metrology subsegment).

The Options Desk tracks the move options price into every US earnings report the week of Sep 7, next to how much each stock has actually moved on its past prints — plus the SPY, QQQ and IWM expected ranges and the gamma walls that box them in.